Nanjing Gaoke Co

Nanjing Gaoke Co Inventory

The Inventory of Nanjing Gaoke Co (600064.SS) as of Nov 3, 2026 is 8.93 B CNY. In the previous year, Inventory was 11.15 B CNY — a change of -19.94% (lower).

Inventory

8.93 BCNY

YoY

-19.94%

Last updated:

Inventory of Nanjing Gaoke Co is 2025 8.93 B CNY. Inventory of Nanjing Gaoke Co was 2024 11.15 B CNY. It decreases by -19.94% lower compared to the previous year.

The Nanjing Gaoke Co Inventory history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Inventory
Date
Inventory
Jan 1, 2018
8.92 B CNY
Jan 1, 2019
9.80 B CNY
Jan 1, 2020
11.82 B CNY
Jan 1, 2021
11.25 B CNY
Jan 1, 2022
13.91 B CNY
Jan 1, 2023
11.34 B CNY
Jan 1, 2024
11.15 B CNY
Jan 1, 2025
8.93 B CNY
The Nanjing Gaoke Co Inventory history
YEARInventoryYoY
8.93 BCNY-19.94%
11.15 BCNY-1.65%
11.34 BCNY-18.46%
13.91 BCNY+23.62%
11.25 BCNY-4.83%
11.82 BCNY+20.67%
9.80 BCNY+9.85%
8.92 BCNY-0.87%
9.00 BCNY+5.50%
8.53 BCNY-0.27%
8.55 BCNY+9.14%
7.84 BCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Nanjing Gaoke Co Stock analysis

What does Nanjing Gaoke Co do? Nanjing Gaoke Co., Ltd. generates revenue through its property and municipal business, pharmaceutical operations, and equity investment activities. The company develops residential and commercial properties, manages real estate assets, and provides municipal services in Nanjing, Jiangsu province. Its pharmaceutical business focuses on research, manufacturing, and selling drugs, while equity investments contribute to its income stream. The primary customers for real estate are residents and businesses seeking residential or commercial spaces, and pharmaceutical buyers include healthcare providers and patients in the local market. The company's property and municipal business serves local communities and businesses in Nanjing, Jiangsu, with residential development and property management as key revenue drivers. Pharmaceutical sales target healthcare institutions and end-users within Jiangsu province, leveraging the firm's R&D capabilities. Equity investment activities support diversified income generation without specifying external partners or markets. Nanjing Gaoke's real estate segment includes residential and commercial projects, while its pharmaceutical division handles drug production and distribution. The firm's municipal services integrate with property management to enhance community offerings. Equity investments provide additional financial returns, though specific investment targets are not detailed in the description. Nanjing Gaoke Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Nanjing Gaoke Co stock

Inventory of Nanjing Gaoke Co is 8.93 B CNY in 2025.

Inventory of Nanjing Gaoke Co changed from 11.15 B CNY to 8.93 B CNY, representing a -19.94% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Inventory Nanjing Gaoke Co since 2006 – with annual values, charts, and detailed analysis.

Inventory includes raw materials, work-in-progress, and finished goods. Efficient inventory management is crucial for profitability.

Inventory's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Inventory's Nanjing Gaoke Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Nanjing Gaoke Co

All Key Metrics — Nanjing Gaoke Co